ritonavir

Paxlovid decreased hospitalisation, risk of death during Omicron wave: Research

Read more

Hetero’s ‘NIRMACOM’ gets WHO Prequalification for COVID-19 treatment

Read more

WHO recommends Pfizer’s Paxlovid for wide geographical distribution

Read more

‘TRIPS Waiver’ must be agreed now, says MSF

Read more

WHO to discontinue hydroxycholorquine trial for COVID-19

Read more

Drug repurposing and its growing significance in India

Read more

New triple antiviral drugs combo shows promise against COVID-19: Study

Read more